Lack of association between human papillomavirus type 16 and 18 infections and female lung cancer

19Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

Abstract

Background: A carcinogenic role of human papillomavirus (HPV) in lung cancer development has been suggested through both clinical and laboratory research during the last two decades. Methods: We did a population-based case-control study nested within the Finnish Maternity Cohort to assess the role of HPV16/18 infections in female lung carcinogenesis. The Finnish Maternity Cohort containing samples from more than 600,000 subjects were linked with nationwide cancer registries (1973-2006). Serum samples were retrieved from 311 women who developed lung cancer and 930 matched controls. The samples were analyzed for antibodies to HPV types 16 and 18 and cotinine (a biomarker of tobacco exposure). Conditional logistic regression-based estimates of odds ratios and 95% confidence intervals adjusted for cotinine levels were calculated. Results: Overall, there was no evidence of increased risk of lung cancer associated with HPV 16 and 18 type-specific infections among nonsmokers and smokers, assessed via cotinine levels. Conclusions: The question of HPVetiologic effect on lung carcinoma deserves further longitudinal studies using different HPV detection methods. Impact: Our results bring new insights into female HPV lung cancer research. ©2010 AACR.

Cite

CITATION STYLE

APA

Simen-Kapeu, A., Surcel, H. M., Koskela, P., Pukkala, E., & Lehtinen, M. (2010). Lack of association between human papillomavirus type 16 and 18 infections and female lung cancer. Cancer Epidemiology Biomarkers and Prevention, 19(7), 1879–1881. https://doi.org/10.1158/1055-9965.EPI-10-0356

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free